Dysregulation of S1P signaling in IBD leads to increased S1P levels in the inflamed mucosa, which promotes immune cell recruitment and leads to persistent inflammation and tissue damage [46]. This evidence concerns the gene MBTPS1 and inflammatory bowel disease.